MS patients denied licensed cannabis drug by NHS
MS patients denied licensed cannabis drug by NHS
The NHS has been criticised by doctors for denying multiple sclerosis patients access to a drug derived from cannabis which regulators have approved to help relieve their symptoms.
MS specialists claim primary care trusts (PCTs) in England are exacerbating patients' pain and suffering by refusing to let them use Sativex. Some PCTs say the drug, which costs £11 a day, is not worth the money, but doctors insist it is the only medication that can help some patients.
Sativex can relieve spasticity, or muscle stiffness, in MS patients. It became the first cannabis-based medicine to be licensed for use in the UK almost a year ago by the Medicines and Healthcare products Regulatory Agency (MHRA). ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1543 Views
-
Last post by frodo
-
- 0 Replies
- 1547 Views
-
Last post by NHE
-
- 0 Replies
- 1676 Views
-
Last post by NHE
-
- 0 Replies
- 534 Views
-
Last post by NHE
-
- 1 Replies
- 3169 Views
-
Last post by Tif
-
- 0 Replies
- 2461 Views
-
Last post by frodo
-
- 0 Replies
- 155 Views
-
Last post by DIM
-
- 5 Replies
- 14556 Views
-
Last post by gibbledygook
-
- 2 Replies
- 1097 Views
-
Last post by DIM